News

Galectin-3, Architect Galectin-3 assay, BG Medicine, Abbott, heart failure, HF

BG Medicine Inc., developer of the BGM Galectin-3 Test, announced that the Architect Galectin-3 assay is now available. This automated blood test was cleared by the United States Food and Drug...

pre-operative testing, NYU Langone, guidelines

Professional physician associations consider certain routine tests before elective surgery to be of low value and high cost, and have sought to discourage their utilization. Nonetheless, a new...

antiplatelet medication, prasugrel, clopidogrel, risk algorithm, SCAI

A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients who stand to benefit from intensive...

A team from Stanford University School of Medicine has developed and combined new paper and flexible polymer substrates with special sensing devices for rapid and accurate detection of pathogens...

CareDx Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high-value, non-invasive surveillance solutions for transplant...

blood urea nitrogen, BUN, postoperative stroke, risk, test, Wake Forest Baptist

The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found...

March 26, 2015 — Siemens Healthcare introduced a new angiography system and new cardiac ultrasound apps at the 2015 American College of Cardiology (ACC) annual meeting.  

ST2, cardiac biomarker, Critical Diagnostics, heart failure, predict outcomes

According to an abstract presented at the American College of Cardiology (ACC) Scientific Sessions in San Diego, elevated levels of the cardiac biomarker ST2 were associated with an increased risk...

Critical Diagnostics announced it has expanded its cardiac biomarker testing product portfolio by CE marking the Aspect-PLUS ST2 test, a rapid quantitative ST2 test. Results are reported in under...

Abbott, troponin, women, myocardial infarction, blood testing, diagnosis

The British Medical Journal published results online that show Abbott’s Architect Stat High Sensitive Troponin-I (hsTnl) test may help doctors to detect twice as...

Siemens, Stratus CS 200, blood testing, cardiac diagnostics, Arab Health 2015

The Diagnostics Division of Siemens Healthcare unveiled its latest point-of-care acute care analyzer for the management of patients with cardiovascular disease symptoms at Medlab in Arab Health...

Nephrocheck Test System, Blood testing, contrast media

Ortho-Clinical Diagnostics Inc. announced the nationwide availability to hospitals of the Nephrocheck Test System designed to help healthcare providers identify patients at risk of developing...

Cleveland HeartLab, MIRISK, heart attack, risk assessment, blood testing

Cleveland HeartLab (CHL) announced that it has acquired the MIRISK cardiovascular disease (CVD) risk assessment tool. Developed at Stanford University School of Medicine and validated in an...

Cardiac diagnostics, blood testing, University of Leicester

A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in patients with diabetes.

A study that identifies new heart attack risk factors and supports the use of a blood test for detection in patients will be published in the AACE (American Association of Clinical...

diaDexus, PLAC Test for Lp-PLA2 Activity,

The U.S. Food and Drug Administration (FDA) cleared a new screening test that predicts a patient’s risk of future coronary heart disease (CHD) events, such as heart attacks.

Alere, INRatio, INRatio2, PT/INR Monitor system, correction

Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio and INRatio 2 PT/INR Monitor system of certain medical conditions that should not be tested with...

CardioDx Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the presentation of the study, "The Use of a Gene Expression Score Showed Clinical...

Akers Biosciences Inc. has signed a feasibility study deal with Konica Minolta Inc. to develop a rapid test for the early detection of myocardial infarction. Heart attacks are the leading cause of...

Singulex Inc. announced the presentation of 10 abstracts at the European Society of Cardiology's (ESC) annual conference, which highlight the clinical utility of single molecule counting...